Clinical Trial Update: Hypertonic Saline Dextran in Pediatric Cardiac Surgery [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 clinical trial evaluating hypertonic saline dextran in pediatric cardiac surgery patients with congenital heart …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrioventricular Septal Defect
• Congenital Heart Defects
• Transposition of the Great Arteries
• Ventricular Septal Defect

Drugs mentioned

• Hypertonic Saline Dextran (Hypertonic saline dextran)

Snippet

Sponsor: Oslo University Hospital | Conditions: Heart Defects, Congenital, Transposition of Great Vessels | Phase 2 | Status: COMPLETED